Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia

被引:7
|
作者
Le, Quy [1 ]
Tang, Thao [1 ]
Leonti, Amanda [1 ]
Castro, Sommer [1 ]
McKay, Cyd Nourigat [1 ]
Perkins, LaKeisha [1 ]
Pardo, Laura [2 ]
Kirkey, Danielle [1 ]
Hylkema, Tiffany [1 ]
Call, Lindsey [1 ]
Manselle, Makia [1 ]
Abrahams, Cristina [3 ]
Bedard, Kristin [3 ]
Molina, Arturo [3 ]
Brodersen, Lisa Eidenshinck [2 ]
Loken, Michael R. [2 ]
Tarlock, Katherine [1 ,5 ]
Meshinchi, Soheil [1 ,4 ,5 ]
Loeb, Keith R. [1 ,6 ,7 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA
[2] Hematologics Inc, Seattle, WA USA
[3] Sutro Biopharma, South San Francisco, CA USA
[4] Univ Washington, Dept Pediat, Seattle, WA USA
[5] Childrens Oncol Grp, Monrovia, CA USA
[6] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[7] Fred Hutch Canc Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA
关键词
INVARIANT CHAIN; PROLIFERATION; SURVIVAL;
D O I
10.1182/bloodadvances.2022008303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1666 / 1670
页数:5
相关论文
共 50 条
  • [21] Preliminary Results of an Ongoing Phase 1 Dose Escalation Study of the Novel Anti-CD74 Antibody Drug Conjugate (ADC), STRO-001, in Patients with B-Cell Non-Hodgkin Lymphoma
    Shah, Nirav N.
    Mattour, Ahmad H.
    Popplewell, Leslie L.
    Andreadis, Charalambos
    Melear, Jason M.
    Spira, Alexander I.
    Shulman, Jonah
    Manda, Sudhir
    Burke, John M.
    Chhabra, Saurabh
    Sharman, Jeff P.
    Krishnan, Amrita
    Shah, Nina
    Dilea, Clifford
    Kuriakose, Jason
    Berman, Craig Jerome
    Matheny, Shannon L.
    Leonard, John P.
    Molina, Arturo
    BLOOD, 2020, 136
  • [22] Preclinical studies of an anti-HER2 antibody-drug conjugate.
    Koeppen, H
    Dugger, D
    Tibbitts, J
    Leipold, D
    Reynolds, T
    Leach, W
    Slikowski, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8980S - 8980S
  • [23] CD33 antibody-drug conjugate for acute myeloid leukaemia
    Smith, Lan-Lan
    LANCET ONCOLOGY, 2017, 18 (01): : 26 - 26
  • [24] Targeting CD56 with an antibody-drug conjugate in Merkel cell carcinoma
    Leiendecker, L.
    Jung, P. S.
    Obenauf, A. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (02) : 209 - 210
  • [25] Generation and preclinical characterization of CD123-CPI antibody-drug conjugate (ADC)
    Han, Yoon-Chi
    Jiang, Fan
    Piche-Nicholas, Nicole
    Katragadda, Madan
    Prashad, Nadira
    Charati, Manoj
    Hu, Wendy
    Leal, Mauricio
    Tumey, Nathan
    Maderna, Andreas
    Dushin, Russell
    Kim, Kenny
    Lemon, LuAnna
    Damelin, Marc
    Gerber, H. P.
    Tchistiakova, Lioudmila
    Loganza, Frank
    O'Donnell, Chris
    Sapra, Puja
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy
    Hau, Andrew
    Zhu, Tong
    Wang, Rengang
    Lau, Megan
    Li, Lingna
    Li, Xiaoqing
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Deng, Dalun
    Yan, Zheng
    Knight, Robert D.
    Kaufmann, Gunnar F.
    Ji, Henry
    Li, Hui
    Zhang, Hong
    BLOOD, 2019, 134
  • [27] CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
    Angelova, Evgeniya
    Audette, Charlene
    Kovtun, Yelena
    Daver, Naval
    Wang, Sa A.
    Pierce, Sherry
    Konoplev, Sergej N.
    Khogeer, Haitham
    Jorgensen, Jeffrey L.
    Konopleva, Marina
    Zweidler-McKay, Patrick A.
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Khoury, Joseph D.
    HAEMATOLOGICA, 2019, 104 (04) : 749 - 755
  • [28] Preclinical Mechanistic Studies Investigating Neutrophil and Lymphoid Cell Depletion By IMGN529, a CD37-Targeting Antibody-Drug Conjugate (ADC)
    Deckert, Jutta
    Ponte, Jose F.
    Coccia, Jennifer A.
    Lanieri, Leanne
    Chicklas, Sharon
    Yi, Yong
    Watkins, Krystal
    Ruiz-Soto, Rodrigo
    Romanelli, Angela
    Lutz, Robert J.
    BLOOD, 2014, 124 (21)
  • [29] Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
    Sherbenou, Daniel W.
    Aftab, Blake T.
    Su, Yang
    Behrens, Christopher R.
    Wiita, Arun
    Logan, Aaron C.
    Acosta-Alvear, Diego
    Hann, Byron C.
    Walter, Peter
    Shuman, Marc A.
    Wu, Xiaobo
    Atkinson, John P.
    Wolf, Jeffrey L.
    Martin, Thomas G.
    Liu, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (12): : 4640 - 4653
  • [30] Preclinical investigation of SGN-CD70A antibody-drug conjugate in T cell lymphomas
    Yang, Chen-Yen
    Wang, Linlin
    Pincus, Laura
    McCormick, Frank
    Gill, Ryan
    Ai, Wei
    CANCER RESEARCH, 2017, 77